India, Sept. 23 -- image credit- freepik

In a step towards preventive and digital-first healthcare, Vidal Health (100% subsidiary of Bajaj Finserv Health), India's second largest TPA service provider and Serum Institute of India (SII), part of Cyrus Poonawalla Group, the world's largest vaccine manufacturer, today announced a strategic collaboration to support national efforts in cervical cancer prevention and awareness.

Starting October 1, 2025, Vidal Health's platform will be the first-of-its-kind to offer an end- to-end, convenient and cashless experience for HPV vaccine - from digitally booking a doctor's appointment at a preferred location, to providing consent and receiving certification - all with zero paperwork. The fully manage...